BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 44 filers reported holding BIOXCEL THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,697 | -81.0% | 21,224 | +226.7% | 0.00% | -100.0% |
| Q3 2020 | $282,000 | +15.6% | 6,497 | -40.5% | 0.00% | 0.0% |
| Q1 2020 | $244,000 | +12.4% | 10,914 | -26.5% | 0.00% | 0.0% |
| Q4 2019 | $217,000 | +24.0% | 14,850 | -7.2% | 0.00% | 0.0% |
| Q2 2019 | $175,000 | -42.1% | 16,000 | -47.6% | 0.00% | 0.0% |
| Q1 2019 | $302,000 | +196.1% | 30,550 | +128.8% | 0.00% | – |
| Q3 2018 | $102,000 | – | 13,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 40,000 | $836,000 | 1.01% |
| ACT CAPITAL MANAGEMENT, LLC | 20,000 | $418,000 | 0.44% |
| Knoll Capital Management, LLC | 20,000 | $418,000 | 0.26% |
| Artemis Investment Management LLP | 1,428,228 | $29,855,000 | 0.24% |
| Rubric Capital Management LP | 268,528 | $5,615,000 | 0.20% |
| Virtus ETF Advisers LLC | 7,713 | $161,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 107,700 | $2,252,000 | 0.05% |
| PDT Partners, LLC | 28,031 | $586,000 | 0.05% |
| AllSquare Wealth Management LLC | 3,162 | $66,000 | 0.04% |
| Hennion & Walsh Asset Management, Inc. | 35,221 | $736,000 | 0.04% |